Ingevity Corporation (NGVT) AI Stock Analysis

Ingevity Corporation manufactures and distributes specialty chemicals and activated carbon materials across global markets. The company operates through two segments: Performance Materials and Performance Chemicals. Performance Materials engineers hardwood-based and chemically activated carbon products primarily applied in automotive vapor emission control systems, as well as food, water, beverage, and chemical purification. Performance Chemicals produces pavement technologies, industrial specialties, and engineered polymers derived from crude tall oil, lignin, and caprolactone chemistries, serving markets like pavement preservation, adhesives, lubricants, coatings, bioplastics, and medical devices.

Ingevity's revenue declined from $1.69B in FY2023 to $1.41B in FY2024 and fell 17.0% to $1.17B in FY2025, reflecting a 5-year revenue CAGR of -0.8%. Despite top-line contraction, gross margin expanded to 39.5% in FY2025 from 32.3% in FY2024, and operating margin reached 22.4%. Annual net income remained negative at -$167.1M in FY2025 following -$430.3M in FY2024. For the trailing twelve months ended June 30, 2026, revenue stood at $1.16B with a profit margin of 4.7% and EPS of $0.70. In the latest quarter, revenue declined 5.2% year-over-year, while quarterly earnings grew 199.0%.

As of June 30, 2026, Ingevity held $97.4M in cash and short-term investments against total debt of $1.24B, resulting in net debt of $1.14B. Shareholders' equity was $46.9M, producing a debt-to-equity ratio of 26.36 and a current ratio of 1.61. In FY2025, operating cash flow reached $331.2M, supporting free cash flow of $273.5M. The company directed capital toward $57.7M in capital expenditures and $56.3M in share buybacks, contributing to a 10.1% reduction in share count over 5 years.

At $69.82, Ingevity trades at a trailing P/E of 99.7x and a forward P/E of 10.0x, compared to medians of 19.7x and 13.4x for its US-listed Basic Materials peers. The stock's price-to-sales multiple is 2.1x, above the peer group median of 1.8x, while its EV-to-EBITDA stands at 17.4x against the peer median of 10.5x. Over the past year, NGVT shares returned 25.8%, outperforming the S&P 500's 16.8% return, though its 5-year return of -10.4% lags the index's 83.0% gain.

Wall Street coverage includes 2 Strong Buy and 1 Buy recommendations, with 0 Hold or Sell ratings. The mean price target is $89.00, representing a 27.5% premium to the last closing price of $69.82. For the fiscal year ending December 31, 2026, consensus estimates project revenue of $1.11B and EPS of $5.24, reflecting 15.2% EPS growth. Ingevity beat EPS estimates in 2 of the last 4 quarters, with its next earnings release scheduled for November 4, 2026.

This page is an AI-written research summary of Ingevity Corporation (NGVT). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: NGVT income statement, NGVT balance sheet, NGVT key metrics, NGVT analyst forecast, NGVT chart. See the NGVT stock overview for the latest quote and news.